A commentary on "Efficacy and safety of short-term (3 days) enoxaparin in preventing venous thromboembolism after gastric cancer surgery: A single-center, prospective cohort study" (Int J Surg 2021; 89:105946)
- PMID: 34555508
- DOI: 10.1016/j.ijsu.2021.106122
A commentary on "Efficacy and safety of short-term (3 days) enoxaparin in preventing venous thromboembolism after gastric cancer surgery: A single-center, prospective cohort study" (Int J Surg 2021; 89:105946)
Comment on
-
Efficacy and safety of short-term (3 days) enoxaparin in preventing venous thromboembolism after gastric cancer surgery: A single-center, prospective cohort study.Int J Surg. 2021 May;89:105946. doi: 10.1016/j.ijsu.2021.105946. Epub 2021 Apr 20. Int J Surg. 2021. PMID: 33892160 Clinical Trial.
References
-
- Kuroda S, Kikuchi S, Kakiuchi Y, Watanabe M, Kuwada K, Tsumura T, Nishizaki M, Kagawa S, Hinotsu S, Fujiwara T. Efficacy and safety of short-term (3 days) enoxaparin in preventing venous thromboembolism after gastric cancer surgery: a single-center, prospective cohort study. Int. J. Surg. 2021;89:105946.
-
- Sakon M, Kobayashi T, Shimazui T. Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study. Thromb. Res . 2010;125(3):e65-e70.
-
- Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. J. Orthop. Sci . 2008;13(5):442-451.
-
- Baumgartner JM, McKenzie S, Block S, Costantini TW, Lowy AM. Prophylactic enoxaparin doses may be inadequate in patients undergoing abdominal cancer surgery. J. Surg. Res . 2018;221:183-189.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
